D. E. Shaw & Co., Inc. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$5,029,349
-8.3%
3,352,899
-27.8%
0.01%
-14.3%
Q3 2022$5,483,000
+39.7%
4,646,464
+33.7%
0.01%
+40.0%
Q2 2022$3,926,000
+146.0%
3,474,536
+551.0%
0.01%
+400.0%
Q1 2022$1,596,000
+632.1%
533,733
+548.6%
0.00%
Q4 2021$218,000
-53.4%
82,287
-36.2%
0.00%
Q3 2021$468,000
+187.1%
128,948
+176.3%
0.00%
Q4 2020$163,000
-51.3%
46,670
-66.6%
0.00%
Q3 2020$335,000
-81.9%
139,661
-86.2%
0.00%
-100.0%
Q2 2020$1,848,000
+193.3%
1,009,413
+149.8%
0.00%
+100.0%
Q1 2020$630,000
-33.7%
404,158
-9.0%
0.00%0.0%
Q4 2019$950,000
-6.6%
443,972
-18.3%
0.00%0.0%
Q3 2019$1,017,000
+55.5%
543,619
+117.0%
0.00%0.0%
Q2 2019$654,000
+179.5%
250,555
+175.2%
0.00%
Q1 2019$234,000
-10.3%
91,032
-19.7%
0.00%
Q4 2018$261,000
-65.2%
113,307
-51.5%
0.00%
-100.0%
Q3 2018$750,000
-58.8%
233,786
-63.7%
0.00%
-50.0%
Q2 2018$1,822,000
-37.4%
643,959
-21.7%
0.00%
-50.0%
Q1 2018$2,910,000
-51.9%
822,042
-47.3%
0.00%
-50.0%
Q4 2017$6,047,000
+57.6%
1,558,425
+3.1%
0.01%
+33.3%
Q3 2017$3,838,000
+3.7%
1,511,197
+11.5%
0.01%0.0%
Q2 2017$3,700,000
-30.9%
1,355,285
-16.3%
0.01%
-33.3%
Q1 2017$5,358,000
+54.7%
1,618,648
+11.2%
0.01%
+50.0%
Q4 2016$3,464,000
-50.9%
1,455,160
-24.3%
0.01%
-50.0%
Q3 2016$7,053,000
+30.7%
1,921,789
-20.6%
0.01%
+20.0%
Q2 2016$5,397,000
+1.2%
2,420,146
-5.6%
0.01%0.0%
Q1 2016$5,335,000
-27.8%
2,564,859
+5.1%
0.01%
-9.1%
Q4 2015$7,393,000
+30.5%
2,439,996
+6.4%
0.01%
+37.5%
Q3 2015$5,665,000
-21.4%
2,293,504
+2.2%
0.01%
-27.3%
Q2 2015$7,206,000
-2.8%
2,244,725
+8.1%
0.01%0.0%
Q1 2015$7,411,000
+109.6%
2,075,981
+33.3%
0.01%
+120.0%
Q4 2014$3,536,000
+20.6%
1,557,324
+3.0%
0.01%
+25.0%
Q3 2014$2,932,000
-51.2%
1,511,340
-8.7%
0.00%
-50.0%
Q2 2014$6,006,000
-4.6%
1,654,492
+2.0%
0.01%
-11.1%
Q1 2014$6,296,000
+48.1%
1,622,737
+8.8%
0.01%
+50.0%
Q4 2013$4,252,000
+8.4%
1,492,097
+36.2%
0.01%0.0%
Q3 2013$3,922,000
+41.7%
1,095,462
+32.2%
0.01%
+20.0%
Q2 2013$2,767,000828,4370.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders